山東墨龍(00568.HK):張恩榮將2.36億股公司A股轉讓給墨龍控股
格隆匯2月23日丨山東墨龍(00568.HK)發佈公吿,公司接到通知,張恩榮先生與壽光墨龍控股有限公司(壽光金鑫的一家直接全資附屬公司)於2021年2月23日訂立了一份股權轉讓協議,雙方一致同意,張恩榮先生將2.36億股A股標的股份轉讓給墨龍控股,墨龍控股同意按照股權轉讓協議約定的條款和條件受讓標的股份。股權轉讓的代價為每股A股人民幣3.50元,即總代價為人民幣8.25億元。
股權轉讓完成後,墨龍控股將持有2.36億股公司A股股份(代表公司已發行股本總額約29.53%),公司實際控制人仍為壽光市國有資產監督管理局。根據表決權委託協議,標的股份的表決權的委託將於股權轉讓完成後終止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.